BR9609281A - Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções - Google Patents

Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções

Info

Publication number
BR9609281A
BR9609281A BR9609281A BR9609281A BR9609281A BR 9609281 A BR9609281 A BR 9609281A BR 9609281 A BR9609281 A BR 9609281A BR 9609281 A BR9609281 A BR 9609281A BR 9609281 A BR9609281 A BR 9609281A
Authority
BR
Brazil
Prior art keywords
antibiotics
positive bacteria
treating infections
bacteria resistant
controlling gram
Prior art date
Application number
BR9609281A
Other languages
English (en)
Inventor
Peter Blackburn
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of BR9609281A publication Critical patent/BR9609281A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9609281A 1995-06-23 1996-06-21 Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções BR9609281A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43595P 1995-06-23 1995-06-23
PCT/US1996/010756 WO1997000694A1 (en) 1995-06-23 1996-06-21 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Publications (1)

Publication Number Publication Date
BR9609281A true BR9609281A (pt) 1999-06-15

Family

ID=21691527

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609281A BR9609281A (pt) 1995-06-23 1996-06-21 Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções

Country Status (18)

Country Link
US (1) US5866539A (pt)
EP (1) EP0833657B1 (pt)
JP (1) JP4236699B2 (pt)
KR (1) KR19990028283A (pt)
CN (1) CN1138560C (pt)
AT (1) ATE247973T1 (pt)
AU (1) AU713050B2 (pt)
BR (1) BR9609281A (pt)
CA (1) CA2225530C (pt)
CZ (1) CZ290578B6 (pt)
DE (1) DE69629691T2 (pt)
ES (1) ES2201189T3 (pt)
IL (2) IL122248A0 (pt)
NO (1) NO976028D0 (pt)
NZ (1) NZ311535A (pt)
RU (1) RU2202360C2 (pt)
SK (1) SK285563B6 (pt)
WO (1) WO1997000694A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
AU770535C (en) * 1999-08-31 2005-02-03 W.L. Gore & Associates, Inc. Improved dental floss having low density and method of making same
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
CN1744905A (zh) * 2002-12-10 2006-03-08 百敖新纳斯有限公司 局部抗感染制剂
EP1940437B1 (en) * 2005-07-28 2013-09-04 Biosynexus Incorporated Compositions and methods for treating bacteria
US7576054B2 (en) * 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
CA2641854A1 (en) * 2006-02-08 2007-08-16 Biosynexus Incorporated Neutralization of bacterial spores
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
WO2010058238A1 (en) * 2008-11-24 2010-05-27 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
KR101107764B1 (ko) * 2009-01-05 2012-01-20 박세준 항 유해균 기능을 가진 에스제이피미생물
JP5719312B2 (ja) 2009-01-14 2015-05-13 ノヴァクタ バイオシステムズ リミティッド デオキシアクタガルジン誘導体
AU2010212183B2 (en) 2009-02-04 2014-07-10 Novacta Biosystems Limited Actagardine derivatives
EP2405742A2 (en) * 2009-03-11 2012-01-18 CryoLife, Inc. Bioburden-reducing antibiotic composition and method of use
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
US8475827B2 (en) 2010-07-06 2013-07-02 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
RU2638814C1 (ru) * 2016-09-27 2017-12-15 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Способ профилактики инфекционных осложнений бактериальной природы после операции на сердце, проведенной в условиях искусственного кровообращения
CN108982430B (zh) * 2017-05-31 2020-09-29 北京大学 标记细菌菌群样品的试剂盒、方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
CZ402597A3 (cs) 1998-09-16
NO976028L (no) 1997-12-22
RU2202360C2 (ru) 2003-04-20
SK285563B6 (sk) 2007-03-01
IL122248A (en) 2009-09-01
CN1188415A (zh) 1998-07-22
NO976028D0 (no) 1997-12-22
EP0833657B1 (en) 2003-08-27
IL122248A0 (en) 1998-04-05
US5866539A (en) 1999-02-02
DE69629691D1 (de) 2003-10-02
DE69629691T2 (de) 2004-02-26
CZ290578B6 (cs) 2002-08-14
JPH11508265A (ja) 1999-07-21
EP0833657A1 (en) 1998-04-08
WO1997000694A1 (en) 1997-01-09
KR19990028283A (ko) 1999-04-15
AU713050B2 (en) 1999-11-25
CN1138560C (zh) 2004-02-18
NZ311535A (en) 2001-05-25
CA2225530A1 (en) 1997-01-09
SK172697A3 (en) 1998-12-02
AU6289196A (en) 1997-01-22
CA2225530C (en) 2002-08-20
ATE247973T1 (de) 2003-09-15
ES2201189T3 (es) 2004-03-16
JP4236699B2 (ja) 2009-03-11

Similar Documents

Publication Publication Date Title
BR9609281A (pt) Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções
CY1108437T1 (el) Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
BR9507099A (pt) Forma de dosagem método de esterilização composição esterilizante e suplemento alimentar animal compreendendo nitrito acidificado como um agente anti-microbiano
GB0026924D0 (en) Antibacterial agents
ES2162796T3 (es) Proteinas biocidas.
DK0736096T3 (da) Antimikrobielle proteiner
DE69828443D1 (de) Säugetierabkömmliche peptide zur behandlung von mikrobiellen infektionen
ES2135254T3 (es) Procedimiento para la degradacion de quinolonas y naftiridonas.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
DE69827814D1 (de) 8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
ATE308895T1 (de) Behandlung von infektionen in tieren
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης
BR9611759A (pt) Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano
ES2165709T3 (es) Uso de la cepa dsm 6601 de escherichia coli para el tratamiento de diarreas en el sector veterinario.
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]